Drugs that inhibit the cellular uptake and/metabolism of cannabinoids such as fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) [184,392] may have benefits against diseases/disorders such as cancer, anxiety, neuropathic path, and inflammatory bowel disease [393]. This evidence concerns the gene MGLL and Anxiety.